Biotech · Private company
MDI Therapeutics, Inc.
Track this companyFree. Adds MDI Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- MDI-2517Phase 1 · Safety and TolerabilityClinicalTrials.gov · fetched Nov 12, 2026
- MDI-2517 1600mgPhase 1 · Safety After Oral IntakeClinicalTrials.gov · fetched Nov 12, 2026
- MDI-2517 2400mgPhase 1 · Safety After Oral IntakeClinicalTrials.gov · fetched Nov 12, 2026
- MDI-2517 3600mgPhase 1 · Safety After Oral IntakeClinicalTrials.gov · fetched Nov 12, 2026
- MDI-2517 800mgPhase 1 · Safety After Oral IntakeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy ParticipantsPHASE1 · COMPLETED · started Nov 4, 2025ClinicalTrials.gov NCT07220889 · fetched Nov 12, 2026
- SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy ParticipantsPHASE1 · COMPLETED · started May 17, 2024ClinicalTrials.gov NCT06453824 · fetched Nov 12, 2026